52-week Open Label Safety-Tolerability Study

ClinicalTrials.gov ID: NCT07369154

Public ClinicalTrials.gov record NCT07369154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 1, 2026, 2:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52 Week, Open Label Safety and Tolerability Study of LB-102 in Adult Patients With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia

Study identification

NCT ID: NCT07369154
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: LB Pharmaceuticals Inc.; Industry
Enrollment: 900 participants

Conditions and interventions

Conditions

Schizophrenia

Interventions

LB-102 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 23, 2026 (Actual)
Primary completion: Dec 2028 (Estimated)
Completion: Apr 2029 (Estimated)
Last update posted: Sep 9, 2026

2026 – 2029

United States locations

U.S. sites: 23
U.S. states: 13
U.S. cities: 21

Facility	City	State	ZIP	Site status
Chandler Clinical Trials	Chandler	Arizona	85224	Recruiting
Pillar Clinical Research	Bentonville	Arkansas	72712	Recruiting
Pillar Clinical Research	Little Rock	Arkansas	72204	Recruiting
Woodland International Research Group	Little Rock	Arkansas	72211	Recruiting
Advanced Research Center	Anaheim	California	92805	Recruiting
Synapse Clinical Trials	Cerritos	California	90703	Recruiting
ProScience Research Group	Culver City	California	90230	Recruiting
CenExel	Culver City	California	92845	Recruiting
Synergy San Diego	San Diego	California	92064	Recruiting
CenExel	Hollywood	Florida	33024	Recruiting
Segal Trials	Miami Lakes	Florida	33063	Recruiting
Health Synergy Clinical Research	West Palm Beach	Florida	33407	Recruiting
CenExel	Atlanta	Georgia	30331	Recruiting
Accelerated Clinical Trial	Snellville	Georgia	30078	Recruiting
Pillar Clinical Research	Chicago	Illinois	60641	Recruiting
CenExel Gaithersburg	Gaithersburg	Maryland	20877	Recruiting
Arch Clinical Trials	St Louis	Missouri	63141	Recruiting
Redbird Research	Las Vegas	Nevada	89119	Recruiting
Neuro-Behavioral Clinical Research	New York	New York	11516	Recruiting
Neuro-Behavioral Clinical Research	Canton	Ohio	44720	Recruiting
Adams Clinical	Philadelphia	Pennsylvania	19104	Recruiting
Adams Clinical	DeSoto	Texas	75115	Recruiting
Pillar Clinical Research	Richardson	Texas	75080	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07369154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 9, 2026 · Synced Oct 1, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07369154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →